Literature DB >> 15878730

Eyeblink conditioning deficits indicate timing and cerebellar abnormalities in schizophrenia.

S M Brown1, P D Kieffaber, C A Carroll, J L Vohs, J A Tracy, A Shekhar, B F O'Donnell, J E Steinmetz, W P Hetrick.   

Abstract

Accumulating evidence indicates that individuals with schizophrenia manifest abnormalities in structures (cerebellum and basal ganglia) and neurotransmitter systems (dopamine) linked to internal-timing processes. A single-cue tone delay eyeblink conditioning paradigm comprised of 100 learning and 50 extinction trials was used to examine cerebellar timing circuits in 13 medicated patients with schizophrenia and 13 age- and sex-matched controls. Patients with schizophrenia showed impaired learning of the conditioned response compared to controls and also greater within-subject variability in the timing of their responses. These findings are consistent with models of schizophrenia in which timing deficits underlie information-processing abnormalities and clinical features of the disorder.

Entities:  

Mesh:

Year:  2005        PMID: 15878730     DOI: 10.1016/j.bandc.2004.09.011

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  40 in total

1.  Impaired delay and trace eyeblink conditioning in school-age children with fetal alcohol syndrome.

Authors:  Sandra W Jacobson; Mark E Stanton; Neil C Dodge; Mariska Pienaar; Douglas S Fuller; Christopher D Molteno; Ernesta M Meintjes; H Eugene Hoyme; Luther K Robinson; Nathaniel Khaole; Joseph L Jacobson
Journal:  Alcohol Clin Exp Res       Date:  2010-11-12       Impact factor: 3.455

Review 2.  The impact of hippocampal lesions on trace-eyeblink conditioning and forebrain-cerebellar interactions.

Authors:  Craig Weiss; John F Disterhoft
Journal:  Behav Neurosci       Date:  2015-08       Impact factor: 1.912

3.  Differential effects of clozapine and haloperidol on interval timing in the supraseconds range.

Authors:  Christopher J MacDonald; Warren H Meck
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

4.  Timing dysfunctions in schizophrenia as measured by a repetitive finger tapping task.

Authors:  Christine A Carroll; Brian F O'Donnell; Anantha Shekhar; William P Hetrick
Journal:  Brain Cogn       Date:  2009-08-06       Impact factor: 2.310

5.  The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders.

Authors:  Tuan D Tran; Aenia Amin; Keith G Jones; Ellen M Sheffer; Lidia Ortega; Keith Dolman
Journal:  J Vis Exp       Date:  2017-08-05       Impact factor: 1.355

6.  Exploration of cerebellar-dependent associative learning in schizophrenia: effects of varying and shifting interstimulus interval on eyeblink conditioning.

Authors:  Amanda R Bolbecker; Adam B Steinmetz; Crystal S Mehta; Jennifer K Forsyth; Mallory J Klaunig; Emily K Lazar; Joseph E Steinmetz; Brian F O'Donnell; William P Hetrick
Journal:  Behav Neurosci       Date:  2011-10       Impact factor: 1.912

7.  Eyeblink conditioning in unmedicated schizophrenia patients: a positron emission tomography study.

Authors:  Krystal L Parker; Nancy C Andreasen; Dawei Liu; John H Freeman; Daniel S O'Leary
Journal:  Psychiatry Res       Date:  2013-10-01       Impact factor: 3.222

8.  Cerebellar-dependent delay eyeblink conditioning in adolescents with Specific Language Impairment.

Authors:  Adam B Steinmetz; Mabel L Rice
Journal:  J Neurodev Disord       Date:  2010-12       Impact factor: 4.025

Review 9.  Explicit Time Deficit in Schizophrenia: Systematic Review and Meta-Analysis Indicate It Is Primary and Not Domain Specific.

Authors:  Valentina Ciullo; Gianfranco Spalletta; Carlo Caltagirone; Ricardo E Jorge; Federica Piras
Journal:  Schizophr Bull       Date:  2015-08-06       Impact factor: 9.306

10.  Eye-blink conditioning deficits indicate temporal processing abnormalities in schizophrenia.

Authors:  Amanda R Bolbecker; Crystal S Mehta; Chad R Edwards; Joseph E Steinmetz; Brian F O'Donnell; William P Hetrick
Journal:  Schizophr Res       Date:  2009-04-05       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.